Drug Trial Radar · NCT07046494
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder
Last checked: Nov 19, 2026Latest source record: Oct 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
253
Actual
Start
Jul 25, 2025
Primary completion
Aug 5, 2026
Study completion Sep 24, 2026
Sponsor
- Lead sponsor
- Rapport Therapeutics Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 1, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a clinical research study for an investigational drug called RAP-219 in participants with bipolar I disorder. This study is being conducted to determine if RAP-219 is safe and effective in participants experiencing mania associated with bipolar I disorder.
Conditions
- Bipolar 1 Disorder
Interventions
RAP-219Drug
RAP-219 tablets administered orally, once daily for 21 days
PlaceboOther
Matching placebo tablets administered orally, once daily for 21 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Young Mania Rating Scale (YMRS)Time frame: Baseline to End of Treatment at Week 3
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
Pillar Clinical Research - Little Rock
Little Rock, Arkansas
Woodland Research Northwest
Rogers, Arkansas
Inland Psychiatric Medical Group - Chino
Chino, California
Synergy Clinical Research Center - San Diego
Lemon Grove, California
Collaborative Neuroscience Research - Los Alamitos
Los Alamitos, California
NRC Research Institute - Orange
Orange, California
NeuroBehavioral Hospitals of the Palm Beaches - South
Boynton Beach, Florida
United Research Institute
Hialeah, Florida
CenExel - Hollywood
Hollywood, Florida
Segal Trials - Miami Lakes Medical Research Early Phase, Inpatient & Outpatient Site
Miami Lakes, Florida
Neuroscience Research Institute at Ambrosia
West Palm Beach, Florida
CenExel - Decatur
Decatur, Georgia
Pillar Clinical Research - Chicago
Chicago, Illinois
CenExel - Gaithersburg
Gaithersburg, Maryland
Arch Clinical Trials
St Louis, Missouri
Richmond Behavioral Associates
Staten Island, New York
New Hope Clinical Research
Charlotte, North Carolina
Community Clinical Research, Inc.
Austin, Texas
HD Research - Memorial Hermann Village
Houston, Texas
Pillar Clinical Research - Richardson
Richardson, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.